What Happened?
Burlingame, CA-based NapaJen Appointed Hironori Ando as Co Founder and Chief Executive Officer
About the Company
A pioneer in immuno-modulation by cell specific delivery of oligonucleotide drugs to antigen presenting cells completing IND enabling studies for a groundbreaking anti-GVHD drug for hematopoietic stem cell transplantation in hematological cancers.
About the Person
Hironori Ando is Co Founder and Chief Executive Officer at NapaJen. Previously, Hironori held various senior HR leadership roles in the industry.
Info Source
News
Short Profile